Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Innovative Drug R&D Services

Deeply integrate R&D experience, constantly climb the peak of R&D technology, and build an integrated innovation service platform for new drug R&D

Innovative Drug R&D Services

Medicilon has establishedglobal-leading new molecule modality R&D platforms and has extensive experience of cutting-edge projects.

Medicilon will continue to use the latest technology to enable global pharmaceutical innovation, and continue to invest substantially in further improving service capabilities for new molecule types, such as PROTAC, oligonucleotide, peptide, ADC, bi-specific antibody, cell and gene therapies, to establish new business opportunities and empower global pharmaceutical innovation.

Medicilon also has rich experience in the molecular design of innovative drugs. We use CADD technology, high-throughput screening and bioelectronic isostereometry technology, to establish a more efficient AI-guided drug design and synthesis platform to help customers improve R&D efficiency and reduce R&D barriers.


Return